[ Price : $8.95]
FDA recommends placing 7-hydroxymitragynine (7-OH) a highly concentrated, synthetic byproduct of the kratom plant under the Contr...[ Price : $8.95]
FDA warns Indias Shiva Analyticals Private Limited about CGMP violations in its work as a contract testing laboratory.[ Price : $8.95]
The CDER Office of Pharmaceutical Quality publishes a white paper making the economic case for quality management practices.[ Price : $8.95]
FDA issues a question-and-answer guidance on the development of certain antibacterial therapies.[ Price : $8.95]
FDA approves a PTC Therapeutics NDA for Sephience (sepiapterin), indicated for treating adult and pediatric patients with phenylke...[ Price : $8.95]
FDA posts the user fee rates for fiscal year 2026 for prescription drugs and biologics, biosimilar, medical devices and generic dr...[ Price : $8.95]
Recognify Life Sciences says its Phase 2b trial of inidascamine, a drug candidate for treating cognitive impairment associated wit...[ Price : $8.95]
After being criticized for attempting to bypass a formal advisory committee review of warnings associated with hormone replacement...